BCL2 and breast carcinoma: In sensitive breast cancer cell lines ATRA can down-regulate the expression of some anti-apoptotic molecules as Bcl-2, cdk2, cyclin D1, and survivin, that are overexpressed in one third of breast cancer types [105,106].